FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907021708> ?p ?o ?g. }

• W2907021708 abstract "BCL2-family proteins have a central role in the mitochondrial apoptosis machinery and their expression is known to be deregulated in many cancer types. Effort in the development of small molecules that selectively target anti-apoptotic members of this family i.e., Bcl-2, Bcl-xL, Mcl-1 recently opened novel therapeutic opportunities. Among these apoptosis-inducing agents, BH3-mimetics (i.e., venetoclax) led to promising preclinical and clinical activity in B cell malignancies. However, several mechanisms of intrinsic or acquired resistance have been described ex vivo therefore predictive markers of response as well as mechanism-based combinations have to be designed. In the present study, we analyzed the expression of the BCL2-family genes across 10 mature B cell malignancies through computational normalization of 21 publicly available Affimetrix datasets gathering 1,219 patient samples. To better understand the deregulation of anti- and pro-apoptotic members of the BCL2-family in hematological disorders, we first compared gene expression profiles of malignant B cells to their relative normal control (naïve B cell to plasma cells, n = 37). We further assessed BCL2-family expression according to tissue localization i.e., peripheral blood, bone marrow, and lymph node, molecular subgroups or disease status i.e., indolent to aggressive. Across all cancer types, we showed that anti-apoptotic genes are upregulated while pro-apoptotic genes are downregulated when compared to normal counterpart cells. Of interest, our analysis highlighted that, independently of the nature of malignant B cells, the pro-apoptotic BH3-only BCL2L11 and PMAIP1 are deeply repressed in tumor niches, suggesting a central role of the microenvironment in their regulation. In addition, we showed selective modulations across molecular subgroups and showed that the BCL2-family expression profile was related to tumor aggressiveness. Finally, by integrating recent data on venetoclax-monotherapy clinical activity with the expression of BCL2-family members involved in the venetoclax response, we determined that the ratio (BCL2+BCL2L11+BAX)/BCL2L1 was the strongest predictor of venetoclax response for mature B cell malignancies in vivo." @default.
• W2907021708 created "2019-01-11" @default.
• W2907021708 creator A5003041443 @default.
• W2907021708 creator A5005550028 @default.
• W2907021708 creator A5010173185 @default.
• W2907021708 creator A5051471778 @default.
• W2907021708 creator A5056464456 @default.
• W2907021708 creator A5068580383 @default.
• W2907021708 creator A5078197703 @default.
• W2907021708 date "2019-01-07" @default.
• W2907021708 modified "2023-10-18" @default.
• W2907021708 title "BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker" @default.
• W2907021708 cites W1876327798 @default.
• W2907021708 cites W1971234510 @default.
• W2907021708 cites W1985563073 @default.
• W2907021708 cites W1990983360 @default.
• W2907021708 cites W1994734311 @default.
• W2907021708 cites W1994740077 @default.
• W2907021708 cites W1995246165 @default.
• W2907021708 cites W1996684127 @default.
• W2907021708 cites W2019447967 @default.
• W2907021708 cites W2023560584 @default.
• W2907021708 cites W2026496528 @default.
• W2907021708 cites W2028553741 @default.
• W2907021708 cites W2029862675 @default.
• W2907021708 cites W2038683465 @default.
• W2907021708 cites W2046517086 @default.
• W2907021708 cites W2048217074 @default.
• W2907021708 cites W2049017785 @default.
• W2907021708 cites W2049135251 @default.
• W2907021708 cites W2050702798 @default.
• W2907021708 cites W2062547838 @default.
• W2907021708 cites W2069057700 @default.
• W2907021708 cites W2073825741 @default.
• W2907021708 cites W2082538818 @default.
• W2907021708 cites W2094052642 @default.
• W2907021708 cites W2096805891 @default.
• W2907021708 cites W2119462367 @default.
• W2907021708 cites W2132276725 @default.
• W2907021708 cites W2133323723 @default.
• W2907021708 cites W2136927291 @default.
• W2907021708 cites W2144881954 @default.
• W2907021708 cites W2149877193 @default.
• W2907021708 cites W2153056550 @default.
• W2907021708 cites W2155165473 @default.
• W2907021708 cites W2192121806 @default.
• W2907021708 cites W2310716991 @default.
• W2907021708 cites W2518731208 @default.
• W2907021708 cites W2520922516 @default.
• W2907021708 cites W2521204548 @default.
• W2907021708 cites W2529212447 @default.
• W2907021708 cites W2553488063 @default.
• W2907021708 cites W2556881192 @default.
• W2907021708 cites W2557469899 @default.
• W2907021708 cites W2559779328 @default.
• W2907021708 cites W2569998106 @default.
• W2907021708 cites W2582696216 @default.
• W2907021708 cites W2584063241 @default.
• W2907021708 cites W2608446199 @default.
• W2907021708 cites W2616581951 @default.
• W2907021708 cites W2620804057 @default.
• W2907021708 cites W2737907117 @default.
• W2907021708 cites W2742091838 @default.
• W2907021708 cites W2753413024 @default.
• W2907021708 cites W2761234508 @default.
• W2907021708 cites W2770858121 @default.
• W2907021708 cites W2800076358 @default.
• W2907021708 cites W2897811394 @default.
• W2907021708 doi "https://doi.org/10.3389/fonc.2018.00645" @default.
• W2907021708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6330761" @default.
• W2907021708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30666297" @default.
• W2907021708 hasPublicationYear "2019" @default.
• W2907021708 type Work @default.
• W2907021708 sameAs 2907021708 @default.
• W2907021708 citedByCount "47" @default.
• W2907021708 countsByYear W29070217082019 @default.
• W2907021708 countsByYear W29070217082020 @default.
• W2907021708 countsByYear W29070217082021 @default.
• W2907021708 countsByYear W29070217082022 @default.
• W2907021708 countsByYear W29070217082023 @default.
• W2907021708 crossrefType "journal-article" @default.
• W2907021708 hasAuthorship W2907021708A5003041443 @default.
• W2907021708 hasAuthorship W2907021708A5005550028 @default.
• W2907021708 hasAuthorship W2907021708A5010173185 @default.
• W2907021708 hasAuthorship W2907021708A5051471778 @default.
• W2907021708 hasAuthorship W2907021708A5056464456 @default.
• W2907021708 hasAuthorship W2907021708A5068580383 @default.
• W2907021708 hasAuthorship W2907021708A5078197703 @default.
• W2907021708 hasBestOaLocation W29070217081 @default.
• W2907021708 hasConcept C104317684 @default.
• W2907021708 hasConcept C121608353 @default.
• W2907021708 hasConcept C127561419 @default.
• W2907021708 hasConcept C149150037 @default.
• W2907021708 hasConcept C150194340 @default.
• W2907021708 hasConcept C190283241 @default.
• W2907021708 hasConcept C203014093 @default.
• W2907021708 hasConcept C2777938653 @default.
• W2907021708 hasConcept C2778461978 @default.
• W2907021708 hasConcept C2779675984 @default.
• W2907021708 hasConcept C2780007613 @default.

• next